Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about NVS
Recent news which mentions NVS
< Previous
1
2
3
4
5
6
7
8
9
...
21
22
Next >
3 Hidden Healthcare Stocks Poised for a Breakout This Year
January 30, 2024
Tickers
MCK
NVS
Tags
TDOC/NYSE
Stocks to Buy
MCK
From
InvestorPlace
Earnings Outlook For Novartis
January 30, 2024
Tickers
NVS
Tags
Benzinga
BZI/EP
NVS
From
Benzinga
Tech Titans Microsoft, Apple Lead 'Magnificent Seven' Earnings Wave This Week: Can Mega-Caps Ignite Market Optimism?
January 29, 2024
Tickers
AAPL
ABBV
AMD
AMZN
Tags
Top Stories
WOLF
SPY
From
Benzinga
Gilead's Tecartus Dropped From FDA List Of CAR-T Therapy With Updated Label Warning Of "Risks Of Secondary Cancer'
January 24, 2024
Tickers
BMY
GILD
JNJ
NEWS
Tags
Benzinga
FDA
GILD
From
Benzinga
Focus On Bristol Myers, Gilead Sciences, Johnson & Johnson, Novartis: FDA To Issue Classwide Black Box Warning on CAR-T Therapies For Blood Cancer Treatment
January 23, 2024
Tickers
AZN
BMY
GILD
GRCL
Tags
JNJ
Stories That Matter
Briefs
From
Benzinga
Cytokinetics' Heart Drug Is A Multi-Billion Dollar Opportunity By 2032 Despite Novartis Setback: Analyst
January 12, 2024
Tickers
AZN
BMY
CYTK
NEWS
Tags
CYTK
Benzinga
Trading Ideas
From
Benzinga
Novartis Retreats From Cytokinetics Deal, Dashing Hopes For Multi-Billion Dollar Acquisition
January 11, 2024
Tickers
CYTK
NEWS
NVS
Tags
Market News
Benzinga
CYTK
From
Benzinga
What's Been Happening With Cytokinetics Stock?
January 09, 2024
Tickers
CYTK
NEWS
NVS
Tags
Market News
CYTK
Benzinga
From
Benzinga
Why Is Heart Failure Drug-Focused Cytokinetic Stock Trading Higher Today?
January 08, 2024
Tickers
CYTK
NEWS
NVS
Tags
M&A
General
Movers
From
Benzinga
Why Is $7B Valued Cancer Focused Exelixis Trading Lower Today?
January 08, 2024
Tickers
EXEL
MRK
NEWS
NVS
Tags
Market News
MRK
Analyst Ratings
From
Benzinga
Google's AI Spin-Off Isomorphic Labs Strikes Big Pharma Deals, Paving the Way for Future of Drug Discovery
January 08, 2024
Tickers
GOOG
GOOGL
LLY
NEWS
Tags
NVS
Briefs
News
From
Benzinga
(NVS) - Analyzing Novartis's Short Interest
January 05, 2024
Tickers
NVS
Tags
Benzinga
Trading Ideas
Short Sellers
From
Benzinga
Voyager Therapeutics Stock Tanked After-Hours - Here's Why
January 04, 2024
Tickers
NEWS
NVS
VYGR
Tags
Movers
Offerings
NVS
From
Benzinga
Big Players' Recent Trades in NVS Options
January 04, 2024
Tickers
NVS
Tags
Benzinga
Options
BZI/UOA
From
Benzinga
VYGR Stock Alert: The $1.2 Billion Reason Voyager Therapeutics Is Up Today
January 02, 2024
Tickers
AZN
NBIX
NVS
VYGR
Tags
NASDAQ:VYGR,NYSE:NVS,NASDAQ:AZN,NASDAQ:NBIX
VYGR
Today's Market
From
InvestorPlace
Why Is Gene Therapy Focused Voyager Therapeutics Stock Soaring Today?
January 02, 2024
Tickers
NEWS
NVS
VYGR
Tags
General
why it's moving
Briefs
From
Benzinga
Why Is Neurology Focused Cingulate Stock Trading Higher Today?
December 28, 2023
Tickers
CING
NEWS
NVS
Tags
Market News
Benzinga
FDA
From
Benzinga
Why Is Cytokinetics (CYTK) Stock Up 70% Today?
December 27, 2023
Tickers
AZN
BMY
CYTK
NVS
Tags
Market News
CYTK
NASDAQ:CYTK,NYSE:BMY,NYSE:NVS,NASDAQ:AZN
From
InvestorPlace
These 3 Big Pharma Stocks Are Making Big Plays With AI
December 22, 2023
Tickers
AZN
LLY
NVS
Tags
LLY
Recent Press Releases
NVS
From
Motley Fool
Calliditas Therapeutics Scores Complete FDA Approval, Broader Label For Lead Kidney Disease Drug
December 21, 2023
Tickers
CALT
MCK
NVS
RHHBY
Tags
General
RHHBY
VERA
From
Benzinga
Fusion's Pharma's Targeted Cancer Therapy Potential Gets This Analyst Bullish, Sees 100% Upside
December 20, 2023
Tickers
AZN
FUSN
NVS
Tags
Small Cap
Biotech
AZN
From
Benzinga
(NVS) - Analyzing Novartis's Short Interest
December 20, 2023
Tickers
NVS
Tags
Short Sellers
Trading Ideas
Benzinga
From
Benzinga
Lantheus Downgraded Due To Reliance On PNT2002; Analyst Cites Comparable Profile To Novartis' Drug
December 19, 2023
Tickers
LNTH
NVS
PNT
Tags
General
LNTH
NVS
From
Benzinga
Are November’s 3 Biggest Stock Losers Worth Snapping Up Now?
December 17, 2023
Tickers
ECX
FSR
FTRE
GELYF
Tags
Market News
ECX
LLY
From
InvestorPlace
FDA Approves Merck's Drug Belzutifan For Type Of Advanced Kidney Cancer In Pretreated Cancer Patients
December 15, 2023
Tickers
MRK
NVS
Tags
General
Health Care
News
From
Benzinga
Novartis' Newly FDA-Approved Rare Blood Disorder Drug Aces Phase 3 Study In Ultra Rare Kidney Failure Disease
December 11, 2023
Tickers
NVS
Tags
Market News
Benzinga
Large Cap
From
Benzinga
This 1 Emerging Risk Could Be a Problem for These 3 Big Pharma Stocks
December 10, 2023
Tickers
BMY
GILD
NVS
Tags
BMY
Recent Press Releases
GILD
From
Motley Fool
Novartis' Rare Blood Disorder Therapy Scores FDA Approval
December 06, 2023
Tickers
NVS
Tags
Benzinga
FDA
Market News
From
Benzinga
(NVS) - Analyzing Novartis's Short Interest
December 01, 2023
Tickers
NVS
Tags
Short Sellers
Trading Ideas
Benzinga
From
Benzinga
Eyes On Novartis, Gilead, Bristol Myers As FDA Weighs Risks Vs. Benefits Of Approved CAR T-Cell Therapies
November 29, 2023
Tickers
BMY
GILD
JNJ
NVS
Tags
Biotech
Large Cap
BMY
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
21
22
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.